USTRx Act

The USTRx Act establishes a new position for a Chief Pharmaceutical Trade Negotiator within the United States Trade Representative office to specifically advocate for and enforce trade agreements related to U.S. pharmaceutical products. The bill requires the USTR to annually identify high-income countries based on World Bank statistics and publish reports evaluating whether their drug pricing policies are fair, transparent, and market-based. If a country’s practices are found to unfairly restrict access or undervalue innovative medicines, the USTR must submit a response plan to Congress within 30 days, which may include initiating trade investigations under existing authority.